Acid reflux, or heartburn, is a common yet one of the most uncomfortable conditions, which often arises due to indigestion, excessive acid formation or other underlying health issues. But what exactly ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
The FDA has approved Cobenfy, a new schizophrenia medication by Bristol Myers Squibb, marking the first novel treatment in decades. Unlike traditional drugs, Cobenfy targets neurotransmitters ...